Withdrawal signs and symptoms occur in infants born to moms who receive barbiturates throughout the last trimester of pregnancy
pentobarbital will lessen the extent or outcome of alprazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will reduce the extent or impact of nelfinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will decrease the extent or impact of bosentan by influencing hepatic enzyme CYP2C9/ten metabolism. Small/Significance Unfamiliar.
pentobarbital will decrease the extent or effect of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the level or outcome of quinine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Not known.
pentobarbital will minimize the level or influence of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Contraindicated (one)pentobarbital will reduce the level or influence of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib can be a delicate CYP3A4 substrate. Coadministration with potent or average CYP3A4 inducers is contraindicated.
pentobarbital will decrease the extent or outcome of budesonide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital and daridorexant equally boost sedation. Modify Therapy/Observe Carefully. Coadministration will increase chance of CNS depression, which may result in additive impairment of psychomotor effectiveness and lead to daytime impairment.
pentobarbital will lessen the extent or influence of etravirine by influencing hepatic enzyme CYP2C9/ten metabolism. Use Warning/Observe.
pentobarbital will reduce the level or result of zonisamide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will lower the level or result of eplerenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unknown.
pentobarbital will reduce the extent here or outcome of disopyramide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Not known.